More data/experience on ‘wearing off phenomenon’ with Ocrevus treatment. Can next infusion be administered at 5 months instead of 6 months to avoid this wearing off phenomenon?
For the 5-25 percent of MS patients who do not experience fatigue as a major symptom, is there a protective factor to be learned? Could we understand why they do not report having the most common symptom?
Do some MS patients who are/have taken Ocrevus have advancing disability when compared to other medications. In particular gait and mobility issues.
I would like to know whether IV Nutrient Therapy could help manage MS symptoms and prevent future disease activity.
How are patients living with both MS and other autoimmune diseases managing symptoms, medications and their medical team?
MS symptoms vary; does age contribute to symptoms stabilizing and/or decreasing as MS people reach their 70's or older?
For those who have urinary incontinence as a symptom can botox be used long term without complications?
Does combining intermittent fasting (IF) with Ocrevus treatment help in reducing MS fog in people with progressive MS?
